SCHEMBL549328

SCHEMBL549328

O=C(Nc1ccc(N2CCC[C@]3(CCN(C4CCC(O)CC4)C3=O)C2)nc1)C1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 1/20 0.45
PTPN1 P18031 2/20 0.42
PTPN2 P17706 1/20 0.42
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
TP53 P04637 1/20 0.39
ALDH1A1 P00352 6/20 0.39
KDM4E B2RXH2 3/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PDE7A Q13946 1/20 0.39
SHMT2 P34897 1/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
DGAT1 O75907 1/20 0.38
MERTK Q12866 2/20 0.38
FLT3 P36888 1/20 0.38
TYRO3 Q06418 1/20 0.38
GAS6 Q14393 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL549564 1.00 CRBN (0.45) CRBNPTPN1PTPN2NPC1RAB9A
SCHEMBL549563 1.00 CRBN (0.45) CRBNPTPN1PTPN2NPC1RAB9A
SCHEMBL549327 1.00 CRBN (0.45) CRBNPTPN1PTPN2NPC1RAB9A
SCHEMBL2700802 1.00 CRBN (0.45) CRBNPTPN1PTPN2NPC1RAB9A
SCHEMBL2700803 1.00 CRBN (0.45) CRBNPTPN1PTPN2NPC1RAB9A
SCHEMBL2700110 0.99 CRBN (0.46) CRBNPTPN1PTPN2NPC1RAB9A
SCHEMBL551021 0.99 CRBN (0.46) CRBNPTPN1PTPN2NPC1RAB9A
SCHEMBL549382 0.99 CRBN (0.46) CRBNPTPN1PTPN2NPC1RAB9A
SCHEMBL2700111 0.99 CRBN (0.46) CRBNPTPN1PTPN2NPC1RAB9A
SCHEMBL551022 0.99 CRBN (0.46) CRBNPTPN1PTPN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8563570-B2 Lactam compounds and their use as pharmaceuticals INCYTE CORPORATION (US) 2013-10-22 US claimed
US-20120122858-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2012-05-17 US claimed
US-20090291946-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2009-11-26 US claimed
US-8563570-B2 Lactam compounds and their use as pharmaceuticals INCYTE CORPORATION (US) 2013-10-22 US disclosed
US-20120122858-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2012-05-17 US disclosed
US-8110581-B2 Lactam compounds and their use as pharmaceuticals INCYTE CORPORATION (US) 2012-02-07 US disclosed
US-20090291946-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291946-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS HSD11B1, HSD11B2, HSD17B1 CRBN 2898/4885PTPN1 2385/4885PTPN2 3580/4885
US-20120122858-A1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS HSD11B1, HSD11B2, HSD17B1 CRBN 2898/4885PTPN1 2385/4885PTPN2 3580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.